{"id":1431,"date":"2026-02-24T13:00:00","date_gmt":"2026-02-24T13:00:00","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/24\/new-real-world-study-supports-long-term-ocrevus-use-in-relapsing-ms\/"},"modified":"2026-02-24T13:00:00","modified_gmt":"2026-02-24T13:00:00","slug":"new-real-world-study-supports-long-term-ocrevus-use-in-relapsing-ms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/24\/new-real-world-study-supports-long-term-ocrevus-use-in-relapsing-ms\/","title":{"rendered":"New real-world study supports long-term Ocrevus use in relapsing MS"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/24\/real-world-study-supports-long-term-ocrevus-use-relapsing-ms\/\" title=\"New real-world study supports long-term Ocrevus use in relapsing MS\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"534\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2025\/12\/iStock-1739325597-800x534.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A smiling patient is being comforted by a doctor.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"159755\" \/><\/a><\/p>\n<p>In real-world clinical practice, Ocrevus (ocrelizumab) showed sustained effectiveness in people with relapsing forms of multiple sclerosis (MS), with most patients remaining free from long-term worsening of disability over four years, according to a new study. Relapse rates and MRI disease activity were also low during follow-up. At four years, 39.7% of patients with available [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/24\/real-world-study-supports-long-term-ocrevus-use-relapsing-ms\/\">New real-world study supports long-term Ocrevus use in relapsing MS<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/24\/real-world-study-supports-long-term-ocrevus-use-relapsing-ms\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In real-world clinical practice, Ocrevus (ocrelizumab) showed sustained effectiveness in people with relapsing forms of multiple sclerosis (MS), with most patients remaining free from long-term worsening of disability over four years, according to a new study. Relapse rates and MRI disease activity were also low during follow-up. At four years, 39.7% of patients with available&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1432,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1431","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1431"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1431\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1432"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}